Terms: = Breast cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Treatment
61 results:
1. Who can benefit from postmastectomy radiotherapy among HR+/HER2- T1-2 N1M0 breast cancer patients? An explainable machine learning mortality prediction based approach.
Jin L; Zhao Q; Fu S; Zhang Y; Wu S; Li X; Cao F
Front Endocrinol (Lausanne); 2024; 15():1326009. PubMed ID: 38375194
[TBL] [Abstract] [Full Text] [Related]
2. Patterns of Anticoagulation Use and All-Cause of Mortality in cancer Patients with Atrial Fibrillation.
Han X; Yang X; Hidru TH; Wang C; Xia Y
Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):244-253. PubMed ID: 38088911
[TBL] [Abstract] [Full Text] [Related]
3. Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial.
Rugo HS; Bardia A; Marmé F; Cortés J; Schmid P; Loirat D; Trédan O; Ciruelos E; Dalenc F; Gómez Pardo P; Jhaveri KL; Delaney R; Valdez T; Wang H; Motwani M; Yoon OK; Verret W; Tolaney SM
Lancet; 2023 Oct; 402(10411):1423-1433. PubMed ID: 37633306
[TBL] [Abstract] [Full Text] [Related]
4. Cost-effectiveness of Trastuzumab Deruxtecan for HER2-low Advanced breast cancer in the United States.
Peng Y; Wang L; Peng L; Liu Q; Yi L; Luo X; Li S; Qin S; Wan X; Tan C; Chen G
Clin Ther; 2023 Oct; 45(10):965-972. PubMed ID: 37537015
[TBL] [Abstract] [Full Text] [Related]
5. Integrated analysis of mRNA and extrachromosomal circular DNA profiles to identify the potential mRNA biomarkers in breast cancer.
Ouyang Y; Lu W; Wang Y; Wang B; Li F; Li X; Bai Y; Wang Y
Gene; 2023 Mar; 857():147174. PubMed ID: 36627094
[TBL] [Abstract] [Full Text] [Related]
6. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study.
Wang DD; Zhang JF; Zhang LH; Niu M; Jiang HJ; Jia FC; Feng ST
Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):594-604. PubMed ID: 36456428
[TBL] [Abstract] [Full Text] [Related]
7. Detecting the expression of HRs and BCL2 via IHC can help identify luminal A-like subtypes of triple-positive breast cancers.
Xu Y; Liang Y; Yin G
Clin Transl Oncol; 2023 Apr; 25(4):1024-1032. PubMed ID: 36376700
[TBL] [Abstract] [Full Text] [Related]
8. Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models.
Singh D; Gupta M; Sarwat M; Siddique HR
Crit Rev Oncol Hematol; 2022 Aug; 176():103751. PubMed ID: 35752426
[TBL] [Abstract] [Full Text] [Related]
9. Improvement of survival in Korean breast cancer patients over a 14-year period: A large-scale single-center study.
Kim H; Lee SB; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Ahn SH
PLoS One; 2022; 17(3):e0265533. PubMed ID: 35294484
[TBL] [Abstract] [Full Text] [Related]
10. Trends in surgical treatment of early-stage breast cancer reveal decreasing mastectomy use between 2003 and 2016 by age, race, and rurality.
Roberson ML; Nichols HB; Olshan AF; Wheeler SB; Reeder-Hayes KE; Robinson WR
Breast Cancer Res Treat; 2022 Jun; 193(2):445-454. PubMed ID: 35286524
[TBL] [Abstract] [Full Text] [Related]
11. Patterns and Trends in Receipt of Opioids Among Patients Receiving treatment for cancer in a Large Health System.
Sabik LM; Eom KY; Sun Z; Merlin JS; Bulls HW; Moyo P; Pruskowski JA; van Londen GJ; Rosenzweig M; Schenker Y
J Natl Compr Canc Netw; 2022 Mar; 20(5):460-467.e1. PubMed ID: 35231900
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy.
Pece S; Sestak I; Montani F; Tillhon M; Maisonneuve P; Freddi S; Chu K; Colleoni M; Veronesi P; Disalvatore D; Viale G; Buus R; Cuzick J; Dowsett M; Di Fiore PP
Eur J Cancer; 2022 Mar; 164():52-61. PubMed ID: 35172273
[TBL] [Abstract] [Full Text] [Related]
13. Determinants of breast-Conserving Therapy in Early-Stage breast cancer Patients: A Nationwide Study.
Machuca MPG; Wu WC; Yu BL; Cheng CT
Clin Breast Cancer; 2022 Jun; 22(4):e473-e479. PubMed ID: 34974964
[TBL] [Abstract] [Full Text] [Related]
14. Risk Factors, Prognostic Factors, and Nomogram for Distant Metastasis in breast cancer Patients Without Lymph Node Metastasis.
Min Y; Liu X; Hu D; Chen H; Chen J; Xiang K; Yin G; Han Y; Feng Y; Luo H
Front Endocrinol (Lausanne); 2021; 12():771226. PubMed ID: 34899606
[TBL] [Abstract] [Full Text] [Related]
15. Intratumoral analysis of digital breast tomosynthesis for predicting the Ki-67 level in breast cancer: A multi-center radiomics study.
Jiang T; Jiang W; Chang S; Wang H; Niu S; Yue Z; Yang H; Wang X; Zhao N; Fang S; Luo Y; Jiang X
Med Phys; 2022 Jan; 49(1):219-230. PubMed ID: 34861045
[TBL] [Abstract] [Full Text] [Related]
16. National cancer Information System Within the Framework of Health Insurance in Colombia: A Real-World Data Approach to Evaluate Access to cancer Care.
Hernández Vargas JA; Ramírez Barbosa PX; Valbuena-Garcia AM; Acuña-Merchán LA; González-Diaz JA; Lopes G
JCO Glob Oncol; 2021 Aug; 7():1329-1340. PubMed ID: 34473526
[TBL] [Abstract] [Full Text] [Related]
17. Mindfulness-based interventions for breast cancer patients in China across outcome domains: a systematic review and meta-analysis of the Chinese literature.
Jing S; Zhang A; Chen Y; Shen C; Currin-McCulloch J; Zhu C
Support Care Cancer; 2021 Oct; 29(10):5611-5621. PubMed ID: 33770259
[TBL] [Abstract] [Full Text] [Related]
18. breast cancer treatment-related arm lymphoedema and morbidity: A 6-year experience in an Australian tertiary breast centre.
Huang YY; Toh PY; Hunt C; Lin JTW; Kamyab R; Ponniah AK
Asia Pac J Clin Oncol; 2022 Feb; 18(1):109-117. PubMed ID: 33629541
[TBL] [Abstract] [Full Text] [Related]
19. Incidence of bone metastases in patients with organ-specific cancers: A nationwide population-based cohort study.
Shih JT; Yeh TT; Wang SH; Shen PH; Wang CC; Chien WC; Chung CH; Wu CC
Int J Clin Pract; 2021 May; 75(5):e13997. PubMed ID: 33400307
[TBL] [Abstract] [Full Text] [Related]
20. Utilization of Hypofractionated Whole-breast Radiotherapy With Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy.
Sayan M; Vergalasova I; Jhawar S; Kumar S; George M; Kowzun M; Potdevin L; Toppmeyer D; Haffty B; Ohri N
Clin Breast Cancer; 2021 Feb; 21(1):31-36. PubMed ID: 32792224
[TBL] [Abstract] [Full Text] [Related]
[Next]
